Neuroblastoma in adolescents: Genetic and clinical characterisation

Clinical and Translational Oncology

Volumn 12, Issue 1, 2010, Pages 49-54

  Castel, Victoria ^a   Villamón, Eva ^b   Cañete, Adela ^a   Navarro, Samuel ^b   Ruiz, Amparo ^b   Melero, Carmen ^c   Herrero, Antonio ^d   Yáñez, Yania ^a   Noguera, Rosa ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

11q; 17q; Adolescents; MLPA; MYCN; Neuroblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; ISOTRETINOIN; LACTATE DEHYDROGENASE;

ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; NEUROBLASTOMA; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SCHOOL CHILD; SOFT TISSUE METASTASIS; SURVIVAL TIME; TRIPLOIDY; TUMOR DIFFERENTIATION;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM METASTASIS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 76049096740     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0466-z     Document Type: Article

References (26)

1. Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of paediatric oncology, 4th edn. JB Lippincott, Philadelphia, pp 895-938
2. Castel V, Canete A (2005) Tumores de la cresta neural. In: Madero L, Munoz A (eds) Hematologia y Oncologia Pediatrica, 2nd edn. Ergon, Madrid, pp 571-586
3. W.B. London R.P. Castleberry K.K. Matthay, et al. 2005 Evidence for an age cut-off greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group J Clin Oncol 23 6459 6465 10.1200/JCO.2005.05.571 1:STN:280:DC%2BD2MvpslKisA%3D%3D 16116153 (Pubitemid 46190236)
4. J. Blatt M.J. Gula S.J. Orlando, et al. 1995 Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis Cancer 76 890 894 10.1002/1097-0142(19950901)76:5<890::AID-CNCR2820760525>3.0.CO;2-X 1:STN:280:DyaK283itlWitQ%3D%3D 8625194
5. L.M. Franks A. Bollen R.C. Seeger, et al. 1997 Neuroblastoma in adults and adolescents: an indolent course with poor survival Cancer 79 2028 2035 10.1002/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0.CO;2-V 1:STN:280:DyaK2s3pt12kuw%3D%3D 9149032 (Pubitemid 27200389)
6. B.H. Kushner K. Kramer N.K. Cheung 2002 Chronic neuroblastoma Cancer 95 1366 1375 10.1002/cncr.10800 12216106 (Pubitemid 35013073)
7. G.M. Brodeur J. Pritchard F. Berthold, et al. 1993 Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 1466 1477 1:STN:280:DyaK3szivFCrug%3D%3D 8336186
8. H. Shimada I.M. Ambros L.P. Dehner, et al. 1999 Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee Cancer 86 349 363 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y 1:STN:280:DyaK1MzkslKnsg%3D%3D 10421272 (Pubitemid 29327593)
9. O. Burgues S. Navarro R. Noguera, et al. 2006 Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry Virchows Arch 449 410 420 10.1007/s00428-006-0253-y 16941154 (Pubitemid 44451315)
10. I.M. Ambros J. Benard M. Boavida, et al. 2003 Quality assessment of genetic markers used for therapy stratification J Clin Oncol 21 2077 2084 10.1200/JCO.2003.03.025 1:STN:280:DC%2BD3s3lt1Srug%3D%3D 12775732 (Pubitemid 46606355)
11. H.R. Slater D.L. Bruno H. Ren, et al. 2003 Rapid high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA) J Med Genet 40 907 912 10.1136/jmg.40.12.907 1:CAS:528:DC%2BD2cXht1aqsb8%3D 14684689
12. E. Villamón M. Piqueras C. Mackintosh, et al. 2008 Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma Virchows Arch 453 47 55 10.1007/s00428-008- 0633-6 18574593
13. N. Gaspar O. Hartmann C. Munzer, et al. 2003 Neuroblastoma in adolescents Cancer 98 349 355 10.1002/cncr.11521 12872356 (Pubitemid 36828461)
14. M. Conte S. Parodi B. De Bernardi, et al. 2006 Neuroblastoma in adolescents: the Italian experience Cancer 106 1409 1417 10.1002/cncr.21751 1:CAS:528:DC%2BD28XjtVCrtr8%3D 16475209 (Pubitemid 43363922)
15. B.H. Kushner K. Kramer M.P. LaQuaglia, et al. 2003 Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience Med Pediatr Oncol 41 508 515 10.1002/mpo.10273 14595707 (Pubitemid 37386067)
16. N. Esiashvili M. Goodman K. Ward, et al. 2007 Neuroblastoma in adults: incidence and survival analysis based on SEER data Pediatr Blood Cancer 49 41 46 10.1002/pbc.20859 16628557 (Pubitemid 46847066)
17. V. Castel A. Cañete R. Noguera, et al. 2005 Neuroblastoma Clin Transl Oncol 7 133 145 10.1007/BF02708748 15899223
18. E.F. Attiyeh W.B. London Y.P. Mossé Children's Oncology Group, et al. 2005 Chromosome 1p and 11q deletions and outcome in neuroblastoma N Engl J Med 353 2243 2253 10.1056/NEJMoa052399 1:CAS:528:DC%2BD2MXht1Gqs7fF 16306521 (Pubitemid 41697287)
19. D. Plantaz J. Vandesompele N. Van Roy, et al. 2001 Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification Int J Cancer 91 680 686 10.1002/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R 1:CAS:528:DC%2BD3MXht1ygtr4%3D 11267980 (Pubitemid 32115264)
20. N. Bown M. Lastowska S. Cotterill U.K. Cancer Cytogenetics Groupthe U.K. Children's Cancer Study Group, et al. 2001 17q gain in neuroblastoma predicts adverse clinical outcome Med Pediatr Oncol 36 14 19 10.1002/1096-911X(20010101) 36:1<14::AID-MPO1005>3.0.CO;2-G 1:STN:280:DC%2BD3MvhsVyqsg%3D%3D 11464868 (Pubitemid 32052988)
21. J. Vandesompele M. Baudis K. De Preter, et al. 2005 Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma J Clin Oncol 23 2280 2299 10.1200/JCO.2005.06.104 1:CAS:528:DC%2BD2MXjsVyhsr8%3D 15800319 (Pubitemid 46218721)
22. C.J. Breen A. O'Meara M. McDermott, et al. 2000 Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization Cancer Genet Cytogenet 120 44 49 10.1016/S0165-4608(99)00252-6 1:CAS:528:DC%2BD3cXksFGjtrk%3D 10913676 (Pubitemid 30410776)
23. Q. Wang S. Diskin E. Rappaport, et al. 2006 Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number Cancer Res 66 6050 6062 10.1158/0008-5472.CAN-05-4618 1:CAS:528:DC%2BD28XlvVSksrs%3D 16778177
24. R.L. Stallings K. Yoon S. Kwek D. Kong 2007 The origin of chromosome imbalances in neuroblastoma Cancer Genet Cytogenet 176 28 34 10.1016/j.cancergencyto.2007.02.014 1:CAS:528:DC%2BD2sXmsFKgsrg%3D 17574961 (Pubitemid 46899212)
25. K.K. Matthay J.G. Villablanca R.C. Seeger, et al. 1999 Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid Children's Cancer Group. N Engl J Med 341 1165 1173 1:STN:280:DyaK1MvjsFGnsg%3D%3D
26. V. Castel A. Cañete S. Navarro, et al. 2001 Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results Med Pediatr Oncol 37 537 542 10.1002/mpo.1248 1:STN:280:DC%2BD3MnpslSmsQ%3D%3D 11745893 (Pubitemid 33101394)